On September 4, 2024, Andrew Turitz, Executive Vice President of Corporate Development at Teladoc Health Inc (TDOC, Financial), executed a sale of 20,773 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider now directly owns 20,773 shares in the company.
Teladoc Health Inc (TDOC, Financial) is a multinational telemedicine and virtual healthcare company. The company offers a range of services including telehealth, medical opinions, AI and analytics, telehealth devices, and licensable platform services.
Over the past year, Andrew Turitz has sold a total of 37,122 shares of Teladoc Health Inc and has not made any purchases of the stock. The insider transaction history for Teladoc Health Inc shows a significant trend with only 2 insider buys and 84 insider sells over the past year.
Shares of Teladoc Health Inc were trading at $7.26 on the day of the transaction. The company has a market cap of approximately $1.313 billion.
The stock's valuation metrics show a GF Value of $27.57, indicating a price-to-GF-Value ratio of 0.26. This suggests that Teladoc Health Inc is currently seen as a Possible Value Trap, Think Twice, according to GuruFocus analysis.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale could be of interest to investors tracking insider behaviors and the valuation levels of Teladoc Health Inc as reflected by the GF Value and market performance indicators.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
